Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial.
Diabetol Metab Syndr
; 15(1): 256, 2023 Dec 07.
Article
em En
| MEDLINE
| ID: mdl-38057876
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article